Topotecan news

All news on Topotecan (also known as Hycamtin): plants, production capacities, investments and involved companies.

10 July 2026

Hansoh Pharma: Ris‑Rez (risvutatug rezetecan) ARTEMIS‑008 shows overall survival benefit in Chinese SCLC patients

Phase III trial met overall survival endpoint in advanced or relapsed small‑cell lung cancer in China, with consistent secondary benefits and no new safety signals.

Who will be producing Topotecan in the future?

Find out with chemXplore Alpha

Learn more